Fosaprepitant | Suppliers | Impurities | Impurity Standards| PharmaCompass.com

Please Wait

Applying Filters...

Fosaprepitant

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 17 USDMF, 3 JDMF, 6 EU WC, 13 NDC API, 22 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 24 FDA Orange Book, 5 Europe, 1 Canada, 8 Australia, 1 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 150MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 7 Kerry, 1 Microlex e.U, 1 Nanjing Bold Chemical, 6 Seppic

EXCIPIENTS BY APPLICATIONS

10 Solubilizers, 6 Parenteral, 5 Fillers, Diluents & Binders, 3 Topical, 3 Co-Processed Excipients, 3 Direct Compression, 3 Emulsifying Agents, 2 Thickeners and Stabilizers, 2 Film Formers & Plasticizers, 2 Surfactant & Foaming Agents, 1 Granulation, 1 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 3 Regulatory FDF Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 2 US Exclusivities, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 Others

2 Others

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

2 All

01 2Piramal Pharma Solutions

filter CAS Number Reset all filters

filter Details Reset all filters

filter Country Reset all filters

Product Main Page

01

Piramal Pharma Solutions

Immuno-Oncology 360

Not Confirmed

02

Piramal Pharma Solutions

Immuno-Oncology 360

Not Confirmed

Contact us
to update this info